Xbrane Biopharma AB. Stock Analysis XBRANE.ST

Xbrane Biopharma AB is a biopharmaceutical company, which engages in the development and manufacture of biosimilars. The company develops biogenerics for injectable slow release drugs and high-yield protein expression technology for the development of biosimilars. The firm's main products are Sperotide, a generic on the originator drug marketed under the trademarks Decapeptyl, Trelstar and Pamorelin, as well as Xlucane, a biosimilar on the originator drug sold under the trademark Lucentis.